Pharmacogenomics Flashcards
Project ENCODE
ENCyclopedia Of DNA Elements
- collaboration of research groups funded by National Human Genome Research Institute (NHGRI)
Project ENCODE
ENCyclopedia Of DNA Elements
- collaboration of research groups funded by National Human Genome Research Institute (NHGRI)
Goal of ENCODE? How do they if a gene is active?
- build a comprehensive parts list of functional elements in the human genome
- including elements that act at the protein and RNA levels, and regulatory elements
How many genes in a human?
20,000
How many chromosomes?
23
How many base pairs?
3 x 10^9 bp
Relationship between chimpanzee and human?
96% homology; 120 x 10^6 bp difference
Genome?
all the genetic material (DNA) of an organism
Genetics?
the study of single genes and its effects
ex: cystic fibrosis, Hunting’s disease
Genomics?
study of all the genes in the genome, including their interactions with environmental factors
ex: heart disease, asthma
Pharmacogenetics?
study of genetic influences on an individual's response to drugs -specific gene, or group of genes to predict responses to a specific drug or class of drugs
Pharmacogenomics? (large scale study)
study of all genes collectively that influence drug responses
- genome-wide analysis
Genome-wide analysis?
identify genes in the search for novel drugs targets; key determinants of drug reactions
How many bp in the human genome?
3 billion
Pharmaceutical relevance of human genome?
What makes pharmacogenomics easy today?
- The human genome sequenced
- ADVANCES in genome seq tech
- AUTOMATIZATION significantly reduced cost in seq
- COMPUTER TECHNOLOGY; handling data
drug spec. trial and error?
- man drugs for certain illnesses
- not enough info about patient (so get info
- Drugs specified by trial and error (does it work, if not tweak it)
- side effects even unknown ones, serious ones
- FDA approval vis DRUG TRIALS
- drugs abandoned b/c of benefited population not convinced
What can help avoid drug spec. trial and error?
Genome based characterization
Cost of drug development?
$500 to $700 million
Drug development timeframe?
12 years
Time until patent expires?
7 years
What is efficacy?
% patients cured at given dose
What is toxicity?
% patients exhibiting side effects at a given dose
Therapeutic index?
Dose range at which drug shows highest efficacy and low toxicity
List 9 of the top 10 causes of death in the U.S. that have genetic component?
1 Heart disease 2 Cancer 3 Cerebrovascular disease 4 Chronic lower respiratory disease 5 (Accidents/unintentional injuries) 6 Diabetes 7 Pneumonia/influenze 8 Alzheimer's disease 9 Kidney disease 10 Septicemia
What are factors the influence drug response?
- gender
- age
- body mass
- diet
- presence of other drugs
- disease
- exposure to certain
- chemicals or toxins
- genetic factors
What can you do to prevent gene-environment interactions?
- screening and medical recommendations
- exposure interventions or prevention to environmental factors
- target messages and interventions aimed at changing behaviors
Current impact of pharmacogenomics in Healthcare practice?
- pharmaceutical industry
- public and private companies
- personalized medicine
Future trends of pharmacogenomics in Heatlhcare practice?
Point-of-care genetic testing
- personal genomics
- population sequencing
Personalized medicine?
- use of individual’s genetic profile
- genetic variation of enzymes that break down or activate drugs (side effects/efficacy)
- prediction of chemotherapy response
Interaction between DNA and Environment: drug
Epigenetic modifications which alter gene expression
Interaction between Environment (drug) and phenotype: drug response?
Drug exposure of sufficient quantity/duration to alter phenotype
Interaction between DNA and Phenotype: drug response?
Functional gene variants: coding SNP promoter variants
Using genetic info to enhance the therapeutic index helps by?
- identifying Non-responders
- not treating those most affected by toxicity
- adjust dose to maximize efficacy while avoiding toxicity; individualized
Clinical implications: Efficacy
- maximize beneficial and therapeutic repsonse
- measure of clinical effectiveness
- % of recipients who show a therapeutic response
Clinical Implications: Toxicity
- unwanted or harmful health effects
- % of patients who show adverse side effects at a given dose
- extreme dose responders
- non responders, drug ineffective
- adverse responders, drug causes major harmful side-effects
Optimal dose range?
Efficacy is greatest and toxicity is lowest
How do you handle non-responders?
increase dose or alternative medication
How do handle adverse responders?
Greatly decrease dose or an alternative form of medication
Describe point-of-care?
Responders treated with drug
Nonresponders enrolled genomically guided clinical trials
How many genes cause exhibit an inherited phenotype?
1200 genes
cystic fibrosis, huntington’s disease
What disease are predisposed by certain genes?
cancer, retinoblastoma, breast cancer, polyposis colorectal cancer
Transcriptome? (Connecting the Genome to gene function)
- all of the expressed RNA molecules in a cell at a given time
- information about how highly various genes are expressed
- different and specific for every cell
- changes in transcriptional activity contributes to a disease
Proteome? (discovering the structure and function of proteins)
- shape-shifting (proteins are continually being synthesized, modified, degraded)
Epigenome? (new tool in studying complex diseases)
- the study of changes in the regulation of gene activity and expression that are not dependent on gene
How is system biology useful?
- screen can bridge the vast amount of molecular characteristics of the disease with